The promising effect of barberry (Zereshk) extract against experimental pulmonary microvascular remodeling and hypertension: A comparison with sildenafil

References

• Archer SL, Weir K, Wilkins MR. (2010). Basic science of pulmonary arterial hypertension for clinicians, new concepts and experimental therapies. Circulation 141:2045–66
   Google Scholar
• Ardestani SB, Sahari MA, Barzegar M, Abbasi S. (2013). Some physicochemical properties of Iranian native barberry fruits (abi and poloei): Berberis integerrima and Berberis vulgaris. J Food Pharm Sci 1:60–7
   Google Scholar
• Barst RJ, McGoon M, Torbicki A, et al. (2004). Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43:40–7
   PubMed Web of Science ®Google Scholar
• Chan S, Loscalzo J. (2008). Pathogenic mechanism of pulmonary arterial hypertension. J Mol Cell Cardiol 44:14–30
   PubMed Web of Science ®Google Scholar
• Chun YT, Yip TT, Lau KL, et al. (1979). A biochemical study on the hypotensive effect of berberine in rats. Gen Pharmacol 10:177–82
   PubMedGoogle Scholar
• Cowan KN, Heilbut A, Humpl T, et al. (2000). Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6:698–702
   PubMed Web of Science ®Google Scholar
• Dai ZK, Tan MS, Chai CY. (2006). Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats. Exp Biol Med 231:942–7
   Web of Science ®Google Scholar
• Dermarderosian A, Beutler JA. (2001). Review of Natural Products: The Most Complete Source of Natural Product Information. Philadelphia: Lippincott Williams & Wilkins
   Google Scholar
• Fatehi M, Saleh TM, Fatehi-Hassanabad Z, et al. (2005). A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol 102:46–52
   PubMed Web of Science ®Google Scholar
• Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. (2005). The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res 19:222–5
   PubMed Web of Science ®Google Scholar
• Frasch HF, Marshall C, Marshall BE. (1999). Endothelin-1 is elevated in monocrotaline pulmonary hypertension. Am J Physiol 1276:L304–10
   Google Scholar
• Humbert M, Morrell NW, Archer SL, et al. (2004). Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S–24
   PubMed Web of Science ®Google Scholar
• Imanshahidi M, Hosseinzadeh H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Berberine. Phytother Res 22:999–1012
   PubMed Web of Science ®Google Scholar
• Ivanovska N, Philipov S. (1996). Study of the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 18:553–61
   PubMed Web of Science ®Google Scholar
• Jasmin JF, Cernacek P, Dupuis J. (2003). Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: Response to chronic ETA receptor blockade. Clin Sci 105:647–53
   PubMed Web of Science ®Google Scholar
• Joukar S, Mahdavi N. (2014). Alterations of blood pressure and ECG following two-week consumption of Berberis integerrima fruit extract. ISRN 2014:209683
   Google Scholar
• Joukar S, Najafipour H, Malekpour-Afshar R, et al. (2010). The effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic hearts. Open Cardiovasc Med J 4:1–6
   PubMedGoogle Scholar
• Joukar S, Shahouzehi B, Najafipour H, et al. (2012). Ameliorative effect of black tea on nicotine induced cardiovascular pathogenesis in rat. EXCLI J 11:309–17
   PubMed Web of Science ®Google Scholar
• Lee S, Lim HJ, Park HY, et al. (2006). Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo berberine improves neointima formation in a rat model. Atherosclerosis 186:29–37
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Maciel BC, Secches AL, Gallo L. (1988). Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol 11:253–60
   PubMed Web of Science ®Google Scholar
• Mathew R, Gloster ES, Sundararajan T, et al. (1997). Role of inhibition of nitric oxide production in monocrotaline induced pulmonary hypertension. J Appl Physiol 82:1493–8
   PubMed Web of Science ®Google Scholar
• Mei Y, Jin H, Tian W, et al. (2011). Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats. Pulm Pharmacol Ther 24:386–93
   PubMed Web of Science ®Google Scholar
• Miyauchi T, Yorikane R, Sakai S, et al. (1993). Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73:887–97
   PubMed Web of Science ®Google Scholar
• Nishida M, Okada Y, Akiyoshi K, et al. (2004). Role of endothelin ETB receptor in the pathogenesis of monocrotaline induced pulmonary hypertension in rats. Eur J Pharmacol 496:159–65
   PubMed Web of Science ®Google Scholar
• Rhodes CH, Davidson A, Wharton J, Wilkins MR. (2009). Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther 121:69–88
   PubMed Web of Science ®Google Scholar
• Sauvageau S, Thorin E, Villeneuve L, Dupuis J. (2009). Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels. Pulm Pharmacol Ther 22:311–17
   PubMed Web of Science ®Google Scholar
• Todd L, Mullen M, Olley PM, Rabinovitch M. (1985). Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res 19:731–7
   PubMed Web of Science ®Google Scholar
• Tomosaka H, Chin YW, Salim AA, et al. (2008). Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry). Phytother Res 22:979–81
   PubMed Web of Science ®Google Scholar
• Widerman RF, Hamal KR. (2011). Idiopathic pulmonary arterial hypertension: An avian model for plexogenic arteriopathy and serotonergic vasoconstriction. J Pharmacol Toxicol Methods 63:283–95
   PubMed Web of Science ®Google Scholar
• Yildiz P. (2009). Molecular mechanisms of pulmonary hypertension. Clin Chim Acta 403:9–16
   PubMed Web of Science ®Google Scholar
• Zovko Koncić M, Kremer D, Karlović K, Kosalec I. (2010). Evaluation of antioxidant activities and phenolic content of Berberis vulgaris and Berberis croatica Horvat. Food Chem Toxicol 48:2176–80
   PubMed Web of Science ®Google Scholar
• Zambelli V, Santaniello A, Fumagalli F, et al. (2011). Efficacy of aminaftone in a rat model of monocrotaline induced pulmonary hypertension. Eur J Pharmacol 667:287–91
   PubMed Web of Science ®Google Scholar